No photo of Roberto Gulminetti

View Scopus Profile

Roberto Gulminetti

  • 710 Citations
  • 16 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Roberto Gulminetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 31 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Genotype Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

  • 710 Citations
  • 16 h-Index
  • 55 Article

Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project

Bagella, P., Squillace, N., Ricci, E., Gulminetti, R., De Socio, G. V., Taramasso, L., Pellicanò, G., Menzaghi, B., Celesia, B. M., Dentone, C., Orofino, G., Bonfanti, P. & Madeddu, G., Jan 1 2019, In : Infection and Drug Resistance. 12, p. 1385-1391 7 p.

Research output: Contribution to journal › Article

Open Access
Lipids
Protease Inhibitors
Reverse Transcriptase Inhibitors
Triglycerides
HDL Cholesterol

Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy

DAU Study Group, Jun 1 2019, In : AIDS (London, England). 33, 7, p. 1256-1260 5 p.

Research output: Contribution to journal › Article

Viral Load
HIV-1
Reverse Transcriptase Inhibitors
Cardiovascular Diseases
HIV

Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

Paolucci, S., Novazzi, F., Piralla, A., Maserati, R., Gulminetti, R., Novati, S., Barbarini, G., Sacchi, P., Fratini, A., Bellotti, L. & Baldanti, F., Jan 1 2019, In : Infection and Drug Resistance. 12, p. 1975-1984 10 p.

Research output: Contribution to journal › Article

Open Access
Hepacivirus
Antiviral Agents
Genotype
RNA
Treatment Failure
6 Citations (Scopus)

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA)

on behalf of CISAI Study Group, Jul 31 2018, In : BMC Infectious Diseases. 18, 1, 357.

Research output: Contribution to journal › Article

Rilpivirine
efavirenz
Integrase Inhibitors
Ritonavir
Protease Inhibitors

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA)

Taramasso, L., Tatarelli, P., Ricci, E., Madeddu, G., Menzaghi, B., Squillace, N., De Socio, G. V., Martinelli, C., Gulminetti, R., Maggi, P., Orofino, G., Vichi, F., Di Biagio, A., Bonfanti, P., Bellacosa, C., Calza, L., Abeli, C., Celesia, B. M., Grosso, C., Stagno, A. & 26 others, Mazzotta, F., Penco, G., Cassola, G., Nicolini, L. A., Dentone, C., Molteni, C., Palvarini, L., Scalzini, A., Carenzi, L., Rizzardini, G., Valsecchi, L., Cordier, L., Rusconi, S., Colombo, V., Galli, M., Franzetti, M., Sgrelli, A., Mazzotta, E., Parruti, G., Bagella, P., Mura, M. S., Libertone, R., Antinori, A., Di Giambenedetto, S., Guastavigna, M. & Caramello, P., 2018, In : BMC Infectious Diseases. 18, 1, 357.

Research output: Contribution to journal › Article